Document Detail

Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients.
MedLine Citation:
PMID:  21442055     Owner:  NLM     Status:  PubMed-not-MEDLINE    
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease globally and commonly associated with insulin resistance and metabolic syndrome (MS). Peroxisome proliferator-activated receptor-γ (PPARγ) is a transcription factor abundantly expressed in adipocytes and plays a key role in the regulation of adipocyte differentiation, lipid and glucose homeostasis. Pro12Ala variant has been earlier associated with obesity, type 2 diabetes and MS.
AIM: The present study aimed to determine the genotype frequencies of the Pro12Ala variant in NAFLD patients and any further association with other phenotype in the patients.
PATIENTS AND METHODS: Ninety-eight NAFLD patients and 280 matched controls were genotyped for presence of the Pro12Ala variant. Genomic DNA was extracted and polymerase chain reaction-restriction fragment length polymorphism using Bst-UI was performed for the detection of C-G change at codon 12 position of PPAR γ2 gene. Genotype and allele frequencies were compared between patients and controls. The Hardy-Weinberg equilibrium was tested by comparing expected/observed genotype frequencies by χ(2) test.
RESULTS: The frequencies of Pro/Ala genotype were comparable between NAFLD patients and controls. In the controls, 213 (75.7%) were homozygous for the wild-type (Pro/Pro) genotype and 67 (23.9%) were heterozygous (Pro/Ala). In NAFLD patients, genotypic distribution of wild type, heterozygous and homozygous were 63 (64.3%), 34 (34.7%) and 1 (1%), respectively. Heterozygous genotype was found to be significantly higher in the patients (P = 0.01). We also analyzed related phenotypic association of the patients with Pro12Ala genotype. We observed that the Pro12Ala (heterozygous) genotype was significantly higher in the patients who had body mass index >25 kg/m(2) (P = 0.025).
CONCLUSIONS: Pro12Ala variation of the PPAR γ2 gene is associated with NAFLD and might play a role in the pathogenesis of NAFLD.
A C Gupta; A K Chaudhory; Sukriti; C Pande; P Sakhuja; Y Singh; S F Basir; S K Sarin
Related Documents :
21123835 - The role of tp53 and mdm2 polymorphisms in tp53 mutagenesis and risk of non-melanoma sk...
21549845 - Mitochondrial dna analysis reveals a unique population structure of the amphidromous sc...
7874125 - Diverse mutations of the p gene among african-americans with type ii (tyrosinase-positi...
8673265 - Identification and characterization of a rapd-pcr marker for distinguishing asian and n...
24238365 - High levels of genetic diversity in nosema ceranae within apis mellifera colonies.
19666645 - Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hyp...
Publication Detail:
Type:  Journal Article     Date:  2010-12-01
Journal Detail:
Title:  Hepatology international     Volume:  5     ISSN:  1936-0541     ISO Abbreviation:  Hepatol Int     Publication Date:  2010  
Date Detail:
Created Date:  2011-03-28     Completed Date:  2011-07-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101304009     Medline TA:  Hepatol Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  575-80     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Radiofrequency ablation of small hepatocellular carcinoma with intravenous pegylated liposomal doxor...
Next Document:  Hepatic vein waveforms in liver cirrhosis re-evaluated.